Gene Therapy's Commercial Manufacturing Issues with Encoded Therapeutics' Andy Stober

<p>Encoded Therapeutics&apos; Chief Manufacturing Officer Andy Stober explains the unique commercial manufacturing issues in gene therapy and how to address them. Stober also shares some of the lessons he&apos;s learned, which may educate the next generation of gene therapy scientists to accelerate future manufacturing success. We also talk about what developers need to consider regarding the ethical responsibilities in gene therapy.</p>